Macheda ML, Rogers S, Best JD. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol. 2005;202:654–62.
Article
PubMed
CAS
Google Scholar
Smith TA. Mammalian hexokinases and their abnormal expression in cancer. Br J Biomed Sci. 2000;57:170–8.
PubMed
CAS
Google Scholar
Cook GJ. Pitfalls in PET/CT interpretation. Q J Nucl Med Mol Imaging. 2007;51:235–43.
PubMed
CAS
Google Scholar
Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med. 1996;23:1409–15.
Article
PubMed
CAS
Google Scholar
Oyama N, Akino H, Suzuki Y, Kanamaru H, Ishida H, Tanase K, et al. FDG PET for evaluating the change of glucose metabolism in prostate cancer after androgen ablation. Nucl Med Commun. 2001;22:963–9.
Article
PubMed
CAS
Google Scholar
Giovannini E, Lazzeri P, Milano A, Gaeta MC, Ciarmiello A. Clinical applications of choline PET/CT in brain tumors. Curr Pharm Des. 2015;21:121–7.
Article
PubMed
CAS
Google Scholar
Olivero WC, Dulebohn SC, Lister JR. The use of PET in evaluating patients with primary brain tumours: is it useful? J Neurol Neurosurg Psychiatry. 1995;58:250–2.
Article
PubMed
CAS
PubMed Central
Google Scholar
Choi Y, Huang SC, Hawkins RA, Hoh CK, Krivokapich J, Buxton DB, et al. A refined method for quantification of myocardial oxygen consumption rate using mean transit time with carbon-11-acetate and dynamic PET. J Nucl Med. 1993;34:2038–43.
PubMed
CAS
Google Scholar
Shreve P, Chiao PC, Humes HD, Schwaiger M, Gross MD. Carbon-11-acetate PET imaging in renal disease. J Nucl Med. 1995;36:1595–601.
PubMed
CAS
Google Scholar
Ho CL, Yu SC, Yeung DW. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med. 2003;44:213–21.
PubMed
Google Scholar
Ponde DE, Dence CS, Oyama N, Kim J, Tai YC, Laforest R, et al. 18F-fluoroacetate: a potential acetate analog for prostate tumor imaging--in vivo evaluation of 18F-fluoroacetate versus 11C-acetate. J Nucl Med. 2007;48:420–8.
PubMed
CAS
Google Scholar
Pillarsetty N, Punzalan B, Larson SM. 2-18F-Fluoropropionic acid as a PET imaging agent for prostate cancer. J Nucl Med. 2009;50:1709–14.
Article
PubMed
CAS
PubMed Central
Google Scholar
Liu RS, Chou TK, Chang CH, Wu CY, Chang CW, Chang TJ, et al. Biodistribution, pharmacokinetics and PET imaging of 18F-FMISO, 18F-FDG and 18F-FAc in a sarcoma- and inflammation-bearing mouse model. Nucl Med Biol. 2009;36(3):305–12.
Article
PubMed
CAS
Google Scholar
Sutcliffe-Goulden JL, O'Doherty MJ, Bansal SS. Solid phase synthesis of [18F]labelled peptides for positron emission tomography. Bioorg Med Chem Lett. 2000;10:1501–3.
Article
PubMed
CAS
Google Scholar
Tang XL, Tang GH, Wang MF, Li BY, Liang MQ, Wang QS. A simple and rapid automated radiosynthesis of [18F]fluoroacetate. J Label Compd Radiopharm. 2008;1:297–301.
Article
Google Scholar
Wang HL, Hu KZ, Tang GH, Huang TT, Liang X. Simple and efficient automated radiosynthesis of 2-18F-fluoropropionic acid using solid-phase extraction cartridges purification. J Label Compd Radiopharm. 2012;55:366–70.
Article
Google Scholar
Marik J, Sutcliffe JL. Fully automated preparation of n.c.a. 4-[18F]fluorobenzoic acid and N-succinimidyl 4-[18F]fluorobenzoate using a Siemens/CTI chemistry process control unit (CPCU). Appl Radiat Isot. 2007;65:199–203.
Article
PubMed
CAS
Google Scholar
Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med. 1995;36:1301–6.
PubMed
CAS
Google Scholar
van Waarde A, Cobben DC, Suurmeijer AJ, Maas B, Vaalburg W, de Vries EF, et al. Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model. J Nucl Med. 2004;45:695–700.
PubMed
Google Scholar
Chang CH, Wang HE, Wu SY, Fan KH, Tsai TH, Lee TW, et al. Comparative evaluation of FET and FDG for differentiating lung carcinoma from inflammation in mice. Anticancer Res. 2006;26:917–25.
PubMed
CAS
Google Scholar
Kuhjda FP. Fatty acid synthase and cancer: new application of an old pathway. Cancer Res. 2006;66:5977–80.
Article
Google Scholar
Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 2007;7:763–77.
Article
PubMed
CAS
Google Scholar
Vavere AL, Kridel SJ, Wheeler FB, Lewis JS. 1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer. J Nucl Med. 2008;49:327–34.
Article
PubMed
CAS
Google Scholar
Lindhe O, Sun A, Ulin J, Rahman O, Langstrom B, Sorensen J. [(18)F]Fluoroacetate is not a functional analogue of [(11)C]acetate in normal physiology. Eur J Nucl Med Mol Imaging. 2009;36:1453–9.
Article
PubMed
CAS
Google Scholar
Fonnum F, Johnsen A, Hassel B. Use of fluorocitrate and fluoroacetate in the study of brain metabolism. Glia. 1997;21:106–13.
Article
PubMed
CAS
Google Scholar
Goncharov NV, Jenkins RO, Radilov AS. Toxicology of fluoroacetate: a review, with possible directions for therapy research. J Appl Toxicol. 2006;26:148–61.
Article
PubMed
CAS
Google Scholar
Kasumov T, Cendrowski AV, David F, Jobbins KA, Anderson VE, Brunengraber H. Mass isotopomer study of anaplerosis from propionate in the perfused rat heart. Arch Biochem Biophys. 2007;463:110–7.
Article
PubMed
CAS
PubMed Central
Google Scholar
Malaisse WJ, Zhang TM, Verbruggen I, Willem R. Enzyme-to-enzyme channelling of Krebs cycle metabolic intermediates in Caco-2 cells exposed to [2-13c]propionate. Biochem J. 1996;317(Pt 3):861–3.
Article
PubMed
CAS
PubMed Central
Google Scholar
Wehrle JP, Ng CE, McGovern KA, Aiken NR, Shungu DC, Chance EM, et al. Metabolism of alternative substrates and the bioenergetic status of EMT6 tumor cell spheroids. NMR Biomed. 2000;13:349–60.
Article
PubMed
CAS
Google Scholar
Ricks CA, Cook RM. Regulation of volatile fatty acid uptake by mitochondrial acyl CoA synthetases of bovine liver. J Dairy Sci. 1981;64:2324–35.
Article
PubMed
CAS
Google Scholar
Huang T, Wang H, Tang G, Liang X, Nie D, Yi C, et al. A comparative uptake study of multiplexed PET tracers in mice with turpentine-induced inflammation. Molecules. 2012;17:13948–59.
Article
PubMed
CAS
Google Scholar
Wang H, Tang X, Tang G, Huang T, Liang X, Hu K, et al. Noninvasive positron emission tomography imaging of cell death using a novel small-molecule probe, (18)F labeled bis(zinc(II)-dipicolylamine) complex. Apoptosis. 2013;18:1017–27.
Article
PubMed
CAS
Google Scholar
Lee TS, Ahn SH, Moon BS, Chun KS, Kang JH, Cheon GJ, et al. Comparison of 18F-FDG, 18F-FET and 18F-FLT for differentiation between tumor and inflammation in rats. Nucl Med Biol. 2009;36:681–6.
Article
PubMed
CAS
Google Scholar
Consolazio A, Alo PL, Rivera M, Iacopini F, Paoluzi OA, Crispino P, et al. Overexpression of fatty acid synthase in ulcerative colitis. Am J Clin Pathol. 2006;126:113–8.
Article
PubMed
CAS
Google Scholar
Ottey KA, Wood LC, Grunfeld C, Elias PM, Feingold KR. Cutaneous permeability barrier disruption increases fatty acid synthetic enzyme activity in the epidermis of hairless mice. J Invest Dermatol. 1995;104:401–4.
Article
PubMed
CAS
Google Scholar
Wakamiya T, Suzuki SO, Hamasaki H, Honda H, Mizoguchi M, Yoshimoto K, et al. Elevated expression of fatty acid synthase and nuclear localization of carnitine palmitoyltransferase 1C are common among human gliomas. Neuropathology. 2014;34:465–74.
Article
PubMed
CAS
Google Scholar
Rombeau JL, Kripke SA. Metabolic and intestinal effects of short-chain fatty acids. JPEN J Parenter Enteral Nutr. 1990;14:181S–5.
Article
PubMed
CAS
Google Scholar
Pathuri G, Agashe HB, Awasthi V, Gali H. Radiosynthesis and in vivo evaluation of a F-18-labeled pancreatic islet amyloid inhibitor. J Label Compd Radiopharm. 2009;53:186–91.
Google Scholar
Pan H, Zhou H, Zeng S, Xu X, An H, Jiang H. Identification and simultaneous determination of p-FHA and p-FBA, two metabolites of anti-tumor agent--Fluorapacin in rat urine. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877:1553–60.
Article
PubMed
CAS
Google Scholar
Awathi V, Pathuri G, Agashe HB, Gali H. Synthesis and in vivo evaluation of p-18F-Fluorohippurate as a new radiopharmaceutical for assessment of renal function by PET. J Nucl Med. 2011;52:147–53.
Article
Google Scholar
He Y, Xu JL, Liu H, Feng M, Wang X, Ding R, et al. Synthesis of 2-R1-2-(4-(2-fluoroethoxy)benzamido)acetate as potential PET imaging agents. Med Chem Res. 2011;11:9577–85.
Google Scholar